Allied Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALID research report →
About the company
Allied Corp. (ALID) specializes in the research, development, and production of cannabinoid health solutions, primarily operating in the United States. The company markets a diverse portfolio of natural health products derived from hemp under various brands.
- CEO
- Michael Moses
- IPO
- 2019
- Employees
- 150
- HQ
- Kelowna, BC, CA
Price Chart
- Market Cap
- $57.75K
- P/E
- -0.00
- P/S
- 0.80
- P/B
- -0.01
- EV/EBITDA
- -0.85
- Div Yield
- 0.00%
- Gross Margin
- -2027.53%
- Op Margin
- -14235.43%
- Net Margin
- -14807.58%
- ROE
- 261.44%
- ROIC
- 1003.32%
- Revenue
- $72.10K · -56.46%
- Net Income
- $-10,675,671 · 36.35%
- EPS
- $-0.11 · 38.89%
- Op Income
- $-10,263,175
- FCF YoY
- 62.76%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.67
- Avg Volume
- 1.02K
Get TickerSpark's AI analysis on ALID
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 27, 23 | Robinson James George | buy | 40,000 |
| Apr 25, 23 | Robinson James George | buy | 40,000 |
Our ALID coverage
Recent articles, reports, and earnings notes.
No research on ALID yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALID report →Similar companies
Peers in the same neighborhood.